Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Broadcom to Proceed in Purchase of VMWare
Broadcom to Proceed in Purchase of VMWare
IRS Delays Tax Reporting Rule Change Again
IRS Delays Tax Reporting Rule Change Again
Nvidia Revenue Beats Estimates
Nvidia Revenue Beats Estimates
OpenAI Announces Sam Altman is Returning as CEO
OpenAI Announces Sam Altman is Returning as CEO
Unemployment Claims Dropped to 209K Last Week
Unemployment Claims Dropped to 209K Last Week
Investigation Into Gulf of Mexico Oil Leak
Investigation Into Gulf of Mexico Oil Leak
U.S. Unemployment Claims Drop by 24,000 to 209,000, Another Sign of Labor Market Resiliency
The number of Americans applying for unemployment benefits fell sharply last week, a sign that U.S. job market remains resilient despite higher interest rates.
OpenAI Brings Back Sam Altman as CEO Just Days After His Firing Unleashed Chaos
The ousted leader of ChatGPT-maker OpenAI is returning to the company that fired him late last week, culminating a days-long power struggle that shocked the tech industry and brought attention to the conflicts around how to safely build artificial intelligence.
Zhao to Step Down as Binance CEO
Zhao to Step Down as Binance CEO
